BICR 31Homo sapiens (Human)Cancer cell line

Also known as: Beatson Institute for Cancer Research 31, BICR31, BICR-31

🤖 AI SummaryBased on 9 publications

Quick Overview

Human squamous cell carcinoma cell line with p53 mutations and immortal characteristics.

Detailed Summary

BICR 31 is a human squamous cell carcinoma (SCC) cell line derived from head and neck tumors. It exhibits immortal characteristics, with a high proliferative capacity in vitro. The cell line is associated with p53 mutations, which are frequently observed in SCCs and contribute to the loss of cell cycle regulation. BICR 31 shows resistance to apoptosis and has been used in studies investigating the role of p53 dysfunction in tumor progression. Additionally, it has been implicated in research on the genetic alterations linked to cellular immortality and the development of head and neck cancers. The cell line is also noted for its ability to form tumors in vivo, making it a valuable model for studying cancer biology and therapeutic responses.

Research Applications

Cancer biologyTumor progressionp53 mutation studiesImmortalization mechanismsDrug response profiling

Key Characteristics

Immortalp53 mutationsResistance to apoptosisTumorigenic in vivo
Generated on 6/18/2025

Basic Information

Database IDCVCL_2312
SpeciesHomo sapiens (Human)
Tissue SourceOral cavity, tongue[UBERON:UBERON_0001723]

Donor Information

Age CategoryUnknown
SexMale
Racecaucasian

Disease Information

DiseaseSquamous cell carcinoma of the oral tongue
LineageHead and Neck
SubtypeOral Cavity Squamous Cell Carcinoma
OncoTree CodeOCSC

DepMap Information

Source TypeECACC
Source IDACH-000228_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Val173_Arg174InsGly (c.518_520delTGA)Homozygous-Unknown, Unknown, PubMed=8390283

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
9,14
D13S317
12
D16S539
11,12
D18S51
16
D21S11
28
D3S1358
15
D5S818
13
D7S820
8,12
D8S1179
13
FGA
24
Penta D
12
Penta E
11
TH01
9
TPOX
10
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.

Keith W.N., Frame M.C.

Oncogene 18:5646-5653(1999).

Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes.

Parkinson E.K.

Oncogene 14:1955-1964(1997).

Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines.

Chapman C., Mitchell R., Robertson G., Soutar D., Parkinson E.K.

Br. J. Cancer 67:1274-1284(1993).

Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss.

Edington K.G., Loughran O.P., Berry I.J., Parkinson E.K.

Mol. Carcinog. 13:254-265(1995).